Merus NV (MRUS)
47.74
+0.55
(+1.17%)
USD |
NASDAQ |
Sep 27, 16:00
47.78
+0.04
(+0.07%)
After-Hours: 20:00
Merus Revenue (Annual): 43.95M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 43.95M |
| December 31, 2022 | 41.59M |
| December 31, 2021 | 49.11M |
| December 31, 2020 | 29.94M |
| December 31, 2019 | 31.13M |
| December 31, 2018 | 38.38M |
| Date | Value |
|---|---|
| December 31, 2017 | 24.86M |
| December 31, 2016 | 1.181M |
| December 31, 2015 | 1.438M |
| December 31, 2014 | 0.9448M |
| December 31, 2013 | 0.261M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
29.94M
Minimum
2020
49.11M
Maximum
2021
39.14M
Average
41.59M
Median
2022
Revenue (Annual) Benchmarks
| uniQure NV | 15.84M |
| ProQR Therapeutics NV | 7.052M |
| argenx SE | 1.226B |
| Pharming Group | 245.32M |
| Pharvaris NV | -- |